Search research articles
Contact Us
Filters
Showing results (1-10 of 207) with videos related to
Page
of 21
Sort By:
Human Gene Therapy
|
June 27, 2008
Clinical application of a retroviral gene transfer protocol based on centrifugation-mediated vector preloading
Boris Fehse
Current Opinion in Molecular Therapeutics
|
November 7, 2003
Mutagenesis by retroviral transgene insertion: risk assessment and potential alternatives
Christopher Baum, Boris Fehse
Innere Medizin (Heidelberg, Germany)
|
May 15, 2024
[How safe is gene therapy? : Second death after Duchenne therapy]
Stefan Horn, Boris Fehse
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 19, 2024
CARs come to AID
Francis Ayuk, Boris Fehse
Kidney International
|
May 22, 2024
The authors reply
Boris Fehse, Nicola M Tomas
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2018
The Time Is Ripe for Somatic Genome Editing: NIH Program to Strengthen Translation
Boris Fehse, Ulrike Abramowski-Mock
Methods in Molecular Biology (Clifton, N.J.)
|
April 30, 2021
mRNA Transfection of T-Lymphocytes by Electroporation
Lea-Isabell Schwarze, Boris Fehse
Seminars in Immunopathology
|
December 7, 2024
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation
Anne Kruchen, Boris Fehse, Ingo Müller
Nature Protocols
|
February 26, 2016
Digital PCR to assess gene-editing frequencies (GEF-dPCR) mediated by designer nucleases
Ulrike Mock, Ilona Hauber, Boris Fehse
Signal Transduction and Targeted Therapy
|
November 6, 2021
How to package and SEND mRNA: a novel "humanized" vector system based on endogenous retroviruses
Kristoffer Riecken, Dawid Głów, Boris Fehse
Page
of 21
Search research articles
Search
Showing results (1-10 of 207) with videos related to
Sort By:
Page
of 21
Human Gene Therapy
|
June 27, 2008
Clinical application of a retroviral gene transfer protocol based on centrifugation-mediated vector preloading
Boris Fehse
Current Opinion in Molecular Therapeutics
|
November 7, 2003
Mutagenesis by retroviral transgene insertion: risk assessment and potential alternatives
Christopher Baum, Boris Fehse
Innere Medizin (Heidelberg, Germany)
|
May 15, 2024
[How safe is gene therapy? : Second death after Duchenne therapy]
Stefan Horn, Boris Fehse
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 19, 2024
CARs come to AID
Francis Ayuk, Boris Fehse
Kidney International
|
May 22, 2024
The authors reply
Boris Fehse, Nicola M Tomas
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2018
The Time Is Ripe for Somatic Genome Editing: NIH Program to Strengthen Translation
Boris Fehse, Ulrike Abramowski-Mock
Methods in Molecular Biology (Clifton, N.J.)
|
April 30, 2021
mRNA Transfection of T-Lymphocytes by Electroporation
Lea-Isabell Schwarze, Boris Fehse
Seminars in Immunopathology
|
December 7, 2024
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation
Anne Kruchen, Boris Fehse, Ingo Müller
Nature Protocols
|
February 26, 2016
Digital PCR to assess gene-editing frequencies (GEF-dPCR) mediated by designer nucleases
Ulrike Mock, Ilona Hauber, Boris Fehse
Signal Transduction and Targeted Therapy
|
November 6, 2021
How to package and SEND mRNA: a novel "humanized" vector system based on endogenous retroviruses
Kristoffer Riecken, Dawid Głów, Boris Fehse
Page
of 21